Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase 2 Study of PF-04691502 vs PF-05212384 in Recurrent Endometrial Cancer
jRCT2080221700Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in endometrial carcinoma (EC) comparing PF-04691502 arm with PF-05212384 arm (2 arms). Started Jan 2012; status: terminated.
02
Drugs
PF-04691502gedatolisib
03
Conditions
endometrial carcinoma (EC)
Beyond the preview
Go deeper on jRCT2080221700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221700.